LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $804,476 | +43.2% | 11,654 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $561,956 | -3.4% | 11,654 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $581,768 | +22.5% | 11,654 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $475,000 | -60.5% | 11,654 | -46.7% | 0.00% | -33.3% |
Q2 2022 | $1,203,000 | +51.3% | 21,877 | 0.0% | 0.00% | +50.0% |
Q1 2022 | $795,000 | +284.1% | 21,877 | +392.8% | 0.00% | – |
Q4 2021 | $207,000 | – | 4,439 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |